Cell Therapy Breakthrough: iPSC Stem Cell Technology Applied
Cell therapy has achieved a new breakthrough: iPSC (induced pluripotent stem cell) technology has entered the clinical application stage in Shanghai.
Read articleLatest updates on cell therapy, medical tourism, and healthcare policy for international patients. AI-curated with sources cited.
Cell therapy has achieved a new breakthrough: iPSC (induced pluripotent stem cell) technology has entered the clinical application stage in Shanghai.
Read articleCerebral palsy is a common motor dysfunction disease in children. Research on umbilical cord blood stem cell treatment for pediatric cerebral palsy has made positive progress, bringing new hope to affected families.
Read articleKnee osteoarthritis is a common disease troubling middle-aged and elderly people. Mesenchymal stem cell joint injection, as a regenerative medicine therapy, is providing a new option for patients with early to mid-stage knee osteoarthritis to relieve pain and delay surgery.
Read articleiPSC (induced pluripotent stem cell) derived cell therapy for macular degeneration has entered the clinical stage, bringing new treatment possibilities for patients with retinal diseases such as age-related macular degeneration.
Read articleChina has made significant progress in stem cell therapy for diabetes: several patients with type 1 diabetes who received stem cell treatment have successfully discontinued insulin injections, and some have remained medication-free for several years.
Read articleShanghai Jiahui International Hospital has officially launched its latest induced pluripotent stem cell (iPSC) treatment platform, another important step forward in the clinical translation of regenerative medicine in Shanghai.
Read articleGet the latest medical insights and healthcare news delivered to your inbox.